A phase II randomized controlled trial of WT1 peptide vaccine (DSP-7888) therapy in patients with childhood, adolescent and young adult soft tissue sarcoma.
Phase of Trial: Phase II
Latest Information Update: 29 Jun 2018
Price : $35 *
At a glance
- Drugs Adegramotide/nelatimotide (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- 12 Jul 2017 Status changed from not yet recruiting to recruiting.
- 23 Feb 2017 New trial record